Cytochrome P-450 CYP3A Inhibitors: all 906 studies that test it
Page 5 of 10. Open to participants first (60), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Appropriateness of the Voriconazole Dosing RegimenCompletedNCT03760276Phase 1
- Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2aCompletedNCT03719313Phase 3
- Control Versus Liberal Cardiac Frequency in Patients in Sepse With Atrial Fibrillation of High Ventricular ResponseStatus unknownNCT03715556Phase 3
- A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND StudyCompletedNCT03710252Phase 4
- Pharmacokinetics of Maraviroc and Boosted Atazanavir Dual Regimen in Stable HIV-infected PatientsWithdrawnNCT03708861Phase 3
- Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin AllergyCompletedNCT03708848Phase 4
- EFFICACY AND SAFETY OF A SIMPLIFICATION STRATEGY BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS OPTIMIZED TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS CARRYING ARCHIVED MULTIDRUG RESISTANCE MUTATIONSCompletedNCT03683524Phase 4
- Body Composition Sub-study of the D2EFT TrialCompletedNCT03675815Phase 4
- Itraconazole in Non Small Cell Lung CancerStatus unknownNCT03664115Phase 2
- A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy SubjectsCompletedNCT03662568Phase 1
- Darunavir and Rilpivirine Interactions With Levonorgestrel ImplantStatus unknownNCT03589027Phase 2
- Genotypic Resistance Guided Therapy for Refractory H. Pylori InfectionStatus unknownNCT03555526Phase 4
- Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori InfectionCompletedNCT03516669Phase 4
- Study in Healthy Subjects to Determine the Effect of an Inhibitor on Exposure to Relacorilant and Its MetabolitesCompletedNCT03512548Phase 1
- Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney DiseaseCompletedNCT03499639Phase 4
- Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1bCompletedNCT03485846Phase 2
- Safety, Tolerability and Pharmacokinetics of PUR1900 (Itraconazole Powder) in Healthy Volunteers and Adults With AsthmaCompletedNCT03479411Phase 1
- Ketoconazole Gel Versus Terconazole Cream for Vaginal CandidiasisStatus unknownNCT03473418Phase 3
- Isotretinoin In Preventing Recurrences In Chronic Recurrent DermatophytosisStatus unknownNCT03471455Phase 2
- Ketoconazole in Treating Participants With Ongoing EGFR Inhibitor-Induced RashCompletedNCT03471364Early Phase 1
- Time-dependent Amiodarone Treatment in Atrial FibrillationCompletedNCT03432663Phase 4
- Safety Trial of Herbal Melanin in Gastritis PatientsStatus unknownNCT03428568Phase 2
- Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA)Status unknownNCT03414918Not applicable
- Tailored Therapy for Helicobacter Pylori Rescue TreatmentCompletedNCT03413020Phase 4
- Same-Day Treatment With Genvoya vs. EFV/TDF/3TCWithdrawnNCT03405194Not applicable
- Assessment of Change in CYP3A Activity by Route of Administration Using Metabolic Markers in Healthy Male VolunteersCompletedNCT03366974Phase 1
- Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune SystemCompletedNCT03345992Phase 3
- Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of XEN1101.CompletedNCT03340220Phase 1
- Comparing the Efficacy of 14-day Reverse Hybrid Therapy and 14-day Triple Therapy Plus Bismuth TherapyStatus unknownNCT03321773Not applicable
- Mifepristone Drug-Drug Interaction Study With CYP3A InhibitorCompletedNCT03259542Phase 1
- Flufenamic Acid for Hospitalised Influenza InfectionStatus unknownNCT03238612Phase 2
- Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS)Status unknownNCT03228823Phase 4
- Bioequivalence Study (Preliminary Study) of Ritonavir Versus NORVIR in Healthy Chinese SubjectsCompletedNCT03214159Phase 1
- Sequential Versus Quadruple Therapy in the Second-line TreatmentStatus unknownNCT03208426Phase 4
- A Trial Testing Amiodarone in Chagas CardiomiopathyStatus unknownNCT03193749Phase 3
- The Study of Efficacy and Safety of 2% Ketoconazole Cream in Thai Females With Mild Degree of Post - Adolescence AcneCompletedNCT03178994Phase 3
- S. Aureus Decolonization in HPN Patients.TerminatedNCT03173053Not applicable
- Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic PurpuraStatus unknownNCT03172676Phase 4
- Using Less Neurotoxic Drugs in Patients With HAND (MARAND-X)TerminatedNCT03163277Phase 4
- Hormonal Mechanisms of Sleep Restriction - Axis StudyActive, not recruitingNCT03142893Phase 1
- Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori TreatmentStatus unknownNCT03139253Phase 4
- 10 vs 14 Days Triple Therapy : H.Pylori Infection EradicationStatus unknownNCT03134378Phase 4
- Periodontal Debridement Associated With Systemic Antibiotics and Single/Repeated PDT to Treat Aggressive PeriodontitisCompletedNCT03132714Phase 2/3
- Intraluminal Therapy for Helicobacter Pylori InfectionCompletedNCT03124420Phase 4
- Adding Bismuth to Rabeprazole-based First-line Triple Therapy Does Not Improve the Eradication of Helicobacter PyloriCompletedNCT03108287Phase 4
- The Pharmacokinetics of Dolutegravir, Darunavir/Cobocistat When Co-administered in Healthy VolunteersCompletedNCT03094507Phase 1
- Changes in Insulin Sensitivity in Healthy Volunteers Taking Tenofovir Alafenamide (TAF)-Containing Antiretroviral MedicationCompletedNCT03092206Phase 1
- A Study of the Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resistant Epithelial Ovarian CancerCompletedNCT03081702Phase 1/2
- Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis PatientsStatus unknownNCT03067883Phase 2
- Clarithromycin + Lenalidomide Combination: a Full Oral Treatment for Patients With Relapsed/Refractory Extranodal Marginal Zone LymphomaCompletedNCT03031483Phase 2
- Propafenone Versus Amiodarone in Septic ShockCompletedNCT03029169Phase 4
- Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.PyloriWithdrawnNCT03021590Phase 4
- To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose AdministrationCompletedNCT03011996Phase 1
- Clarithromycin,Lenalidomide and Dexamethasone for Relapsed/Refractory MyelomaWithdrawnNCT02986451Phase 2
- Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult ParticipantsCompletedNCT02984852Phase 1
- A Study of Lonafarnib With or Without Ritonavir in Patients With HDVWithdrawnNCT02968641Phase 2
- Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic LeukemiaCompletedNCT02948283Phase 1
- Tailored Versus Empiric Therapy for Helicobacter Pylori TreatmentCompletedNCT02935010Phase 4
- Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contractions in Patients With Structural Heart DiseaseCompletedNCT02924285Phase 3
- Pharmacokinetics of Two Different Formulation of VoriconazoleCompletedNCT02912156Phase 4
- Influence of SLCO2B1 Polymorphism on the PK of Voriconazole in CYP2C19 PMCompletedNCT02906176Phase 1
- A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological MalignancyTerminatedNCT02895529Phase 4
- A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLCStatus unknownNCT02852083Phase 2
- MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1bCompletedNCT02845843Phase 2/3
- Clinical Trial to Evaluate Drug-drug Interactions Between Darunavir/Cobicistat and Etravirine in Hiv- Infected PatientsCompletedNCT02818348Phase 1
- Traditional Chinese Medicine Combined With Standard Triple Region for Eradication of Helicobacter PyloriCompletedNCT02803216Phase 1/2
- Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted With Cobicistat in Healthy VolunteersCompletedNCT02771249Phase 1
- Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring ProphylaxisCompletedNCT02755857Phase 2
- Itraconazole as a Targeted Therapy for Inhibiting Hedgehog Pathway Signaling in Esophageal Cancer PatientsStatus unknownNCT02749513Early Phase 1
- Topical Itraconazole in Treating Patients With Basal Cell CancerCompletedNCT02735356Early Phase 1
- Treatment of Postoperative Atrial Fibrillation - Comparison of Amiodarone and Placebo.Status unknownNCT02715687Phase 3
- Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell CancerWithdrawnNCT02699723Early Phase 1
- Pilot Study to Compare Topical Voriconazole to Placebo as a Pain Reducing AgentWithdrawnNCT02689713Phase 2
- Evaluation of Low-dose Darunavir in a Switch StudyCompletedNCT02671383Phase 3
- The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori PatientsCompletedNCT02648659Phase 4
- Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/PCompletedNCT02634008Phase 3
- PK of Efavirenz & Lopinavir Nano-formulations in Healthy VolunteersSuspendedNCT02631473Phase 1
- Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple MyelomaStatus unknownNCT02624440Phase 2
- Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mgCompletedNCT02621905Phase 4
- A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady StateCompletedNCT02608034Phase 1
- SSAT067 PK of Atazanavir/Cobicistat and Darunavir/CobicistatCompletedNCT02589158Phase 1
- Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and DermatophytosisCompletedNCT02582177Phase 3
- A Bioequivalence Study of Darunavir, Emtricitabine, and Tenofovir Alafenamide, in the Presence of Cobicistat in Healthy ParticipantsCompletedNCT02578550Phase 1
- GEM-CLARIDEX: Ld vs BiRdStatus unknownNCT02575144Phase 3
- Clarithromycin in Multiple Myeloma Induction TherapyTerminatedNCT02573935Phase 2
- A Drug-drug Interaction Study Between Daclatasvir and Atazanavir/Ritonavir or Atazanavir/CobicistatCompletedNCT02565888Phase 1
- DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO)CompletedNCT02555943Phase 2/3
- Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected IndividualsTerminatedNCT02503462Phase 4
- Darunavir/Cobicistat and Dolutegravir to Maintain Virologic Suppression and Reduce NRTI-associated ToxicityWithdrawnNCT02499978Phase 2/3
- A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male VolunteersCompletedNCT02493738Phase 1
- Relative Bioavailability and Food Effect for Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fixed Dose CombinationCompletedNCT02475135Phase 1
- Cost-effectiveness of Different Antiretroviral Treatment in Patients HIV NaiveWithdrawnNCT02470650Phase 4
- Understanding HCV Reinfection Rates in an Incarcerated Population After Cure With Interferon Free HCV TreatmentActive, not recruitingNCT02460133Phase 4
- Study in Healthy Male Subjects to Evaluate the Effect of Itraconazole and Rifampicin on the PK of FedovapagonCompletedNCT02440841Phase 1
- A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary AspergillosisCompletedNCT02440009Phase 2/3
- Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical TrialCompletedNCT02431975Phase 4
- Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter PyloriStatus unknownNCT02422706Phase 3
- Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer?TerminatedNCT02416570Phase 2
- Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve SubjectsStatus unknownNCT02404233Phase 4
- ATRA, Celecoxib, and Itraconazole as MaintenanceCompletedNCT02401295Phase 1